UBS analyst Brian Meredith raised the firm’s price target on Ryan Specialty to $67 from $63 and keeps a Buy rating on the shares. The macro environment continues to support good fundamentals for the life insurers and the firm expects P&C earnings to reflect strong fundamentals with some caution in results from uncertain “tort” inflation, the analyst tells investors in a set of preview notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN: